Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics of tuberculosis

G L Marks1

  • 1Department of Medicine, University of South Alabama College of Medicine, Mobile.

The Medical Clinics of North America
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Molecular methods offer rapid identification and drug susceptibility testing for difficult-to-grow pathogens like mycobacteria. These advanced techniques promise faster diagnosis and treatment, crucial for combating diseases like tuberculosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.

Clinical therapeutics·2000
Same author

Transcriptional characterization of the Rickettsia prowazekii major macromolecular synthesis operon.

Journal of bacteriology·1997
Same author

Characterization of the gene coding for the Rickettsia prowazekii DNA primase analogue.

Gene·1993
Same author

Isolation and characterization of the gene coding for the major sigma factor of Rickettsia prowazekii DNA-dependent RNA polymerase.

Gene·1992
Same author

Nucleotide sequence of the Rickettsia prowazekii greA homolog.

Nucleic acids research·1992
Same author

Fatal necrotizing otitis externa in a patient with AIDS.

Reviews of infectious diseases·1991
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Area of Science:

  • Molecular microbiology
  • Clinical diagnostics
  • Pathogen identification

Background:

  • Traditional culture methods for mycobacteria are slow, difficult, or hazardous.
  • Accurate and rapid identification of mycobacteria and their drug resistance is critical for effective treatment.
  • The dual epidemics of HIV and TB necessitate advanced diagnostic approaches.

Purpose of the Study:

  • To review current and emerging molecular methods for mycobacterial diagnostics.
  • To highlight the potential of these technologies for clinical microbiology laboratories.
  • To discuss the implications for tuberculosis and other mycobacterial disease management.

Main Methods:

  • DNA hybridization probes
  • Restriction Fragment Length Polymorphism (RFLP) analysis

Related Experiment Videos

  • Polymerase Chain Reaction (PCR)
  • Ligase Chain Reaction (LCR)
  • Mycobacteriophage reporter-gene assay

    • Main Results:

    • Molecular methods enable direct detection, identification, and drug susceptibility determination from clinical specimens.
    • Technologies like PCR are becoming routine, while others like LCR and phage assays show future promise.
    • These methods can provide results in days, significantly reducing the time compared to weeks or months for conventional methods.

    Conclusions:

    • Molecular diagnostics are revolutionizing mycobacterial disease management.
    • Despite current costs, molecular methods offer long-term cost-effectiveness by improving patient outcomes and infection control.
    • Continued research is essential to develop efficient and cost-effective molecular strategies for global health challenges.